TUMOR-MARKERS IN PATIENTS WITH ADVANCED BREAST-CANCER AS PROGNOSTICATORS - A PRELIMINARY-STUDY

被引：21

作者：

BHATAVDEKAR, JM

PATEL, DD

KARELIA, NH

VORA, HH

GHOSH, N

SHAH, NG

BALAR, DB

TRIVEDI, SN

机构：

[1] Gujarat Cancer Society, Division of Research, Asarwa, Ahmedabad

来源：

BREAST CANCER RESEARCH AND TREATMENT | 1994年 / 30卷 / 03期

关键词：

PROLACTIN; CEA; CA; 15-3; IGF-1; EGF; ADVANCED BREAST CANCER;

D O I：

10.1007/BF00665970

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A retrospective study was performed on 69 breast cancer patients (stage II, N=18; advanced disease, N=51) in order to assess the prognostic value of circulating prolactin (PRL), CEA, CA 15-3, insulin-like growth factor-1 (IGF-1), and epidermal growth factor (EGF) by RIA/IRMA. These markers were compared with short-term prognosis (two years). Significant difference was observed only for PRL (<20.0 ng/ml vs. >20.0 ng/ml), which provide an independent predictor of short-term prognosis in advanced breast cancer.

引用

页码：293 / 297

页数：5

共 23 条

[11]

FOEKENS JA, 1989, CANCER, V63, P2139, DOI 10.1002/1097-0142(19890601)63:11<2139::AID-CNCR2820631112>3.0.CO

[12]

2-D

[13] PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN NODE-POSITIVE BREAST-CANCER [J].